Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tony Antoniou

Showing results (101-110 of 162) with videos related to

Pageof 17
Sort By:
Plos One|February 11, 2021
Herpes zoster in older adults in Ontario, 2002-2016: Investigating incidence and exploring equitySarah A Buchan, Nick Daneman, Jun Wang, et al.
AIDS Care|December 22, 2009
Long-term efficacy and safety of polyalkylimide gel for the treatment of HIV-associated lipoatrophyTony Antoniou, Janet M Raboud, Colin Kovacs, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2007
Outcomes of dosage adjustments used to manage antiretroviral drug interactionsLaura Y Park-Wyllie, Mitchell A Levine, Anne Holbrook, et al.
BMJ (Clinical Research Ed.)|September 14, 2011
Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control studyTony Antoniou, Tara Gomes, Muhammad M Mamdani, et al.
Addiction (Abingdon, England)|March 8, 2022
Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population-based propensity-score matched cohort studyTara Gomes, Daniel McCormack, Nikki Bozinoff, et al.
BMC Pediatrics|February 8, 2025
Association between a publicly funded universal drug program and antipsychotic and antidepressant medication dispensing to childrenSophie A Kitchen, Tara Gomes, Mina Tadrous, et al.
Frontiers in Psychiatry|May 30, 2023
Adherence to antipsychotic laboratory monitoring guidelines in children and youth: a population-based studyTony Antoniou, Tianru Wang, Kathleen Pajer, et al.
Frontiers in Pediatrics|December 26, 2023
Impact of the COVID-19 pandemic on antidepressant and antipsychotic use among children and adolescents: a population-based studyTony Antoniou, Kathleen Pajer, William Gardner, et al.
Annals of Internal Medicine|August 25, 2018
Pregabalin and the Risk for Opioid-Related Death: A Nested Case-Control StudyTara Gomes, Simon Greaves, Wim van den Brink, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|January 17, 2012
Immunologic effectiveness of maraviroc- and raltegravir-containing regimens (R+M+) versus raltegravir-based regimens that do not include maraviroc (R+M-)Tony Antoniou, Graham Smith, Desheng Su, et al.
Pageof 17

Showing results (101-110 of 162) with videos related to

Sort By:
Pageof 17
Plos One|February 11, 2021
Herpes zoster in older adults in Ontario, 2002-2016: Investigating incidence and exploring equitySarah A Buchan, Nick Daneman, Jun Wang, et al.
AIDS Care|December 22, 2009
Long-term efficacy and safety of polyalkylimide gel for the treatment of HIV-associated lipoatrophyTony Antoniou, Janet M Raboud, Colin Kovacs, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2007
Outcomes of dosage adjustments used to manage antiretroviral drug interactionsLaura Y Park-Wyllie, Mitchell A Levine, Anne Holbrook, et al.
BMJ (Clinical Research Ed.)|September 14, 2011
Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control studyTony Antoniou, Tara Gomes, Muhammad M Mamdani, et al.
Addiction (Abingdon, England)|March 8, 2022
Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population-based propensity-score matched cohort studyTara Gomes, Daniel McCormack, Nikki Bozinoff, et al.
BMC Pediatrics|February 8, 2025
Association between a publicly funded universal drug program and antipsychotic and antidepressant medication dispensing to childrenSophie A Kitchen, Tara Gomes, Mina Tadrous, et al.
Frontiers in Psychiatry|May 30, 2023
Adherence to antipsychotic laboratory monitoring guidelines in children and youth: a population-based studyTony Antoniou, Tianru Wang, Kathleen Pajer, et al.
Frontiers in Pediatrics|December 26, 2023
Impact of the COVID-19 pandemic on antidepressant and antipsychotic use among children and adolescents: a population-based studyTony Antoniou, Kathleen Pajer, William Gardner, et al.
Annals of Internal Medicine|August 25, 2018
Pregabalin and the Risk for Opioid-Related Death: A Nested Case-Control StudyTara Gomes, Simon Greaves, Wim van den Brink, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|January 17, 2012
Immunologic effectiveness of maraviroc- and raltegravir-containing regimens (R+M+) versus raltegravir-based regimens that do not include maraviroc (R+M-)Tony Antoniou, Graham Smith, Desheng Su, et al.
Pageof 17